Global Autotransfusion Devices Market

Global Autotransfusion Devices Market (by Type, Application, End User & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)


Market Insight:

Autotransfusion devices are used in medical procedures where the patient's own blood is reintroduced into the body following normal filtration. To put it another way, the patient turns into their own blood benefactor. It is easy to use and removes the infection before the blood is transfused back into the patient’s body.

These devices are commonly used in surgical procedures such as cardiac surgery, organ transplantation and other invasive procedures in which there is excessive blood loss. Factors that are contributing to the growth of the market are an increase in accidents, less availability of patients with rare blood group and high bleeding surgeries. The global autotransfusion devices market is foreseen to reach US$1.15 billion in 2023, growing at a CAGR of 5.78% during the forecasted period.

Segment Covered:
  • By Type: The global autotransfusion devices market can be divided into two segments based on types: Product and Accessories. The products are further segmented into intraoperative, postoperative and dual mode. The intraoperative segment lead the autotransfusion product market, accounted for the highest share. Intraoperative Product is more thriving in the autotransfusion devices market because they usually helped in open heart surgeries, where blood loss is very high and being an important organ, the blood transfusion needs to be quick to restore the patient’s blood loss.
  • By Application: In terms of application, the report includes the segmentation into four categories namely Cardiac Surgeries, Orthopedic Surgeries, Trauma Procedures, and Others. Cardiac Surgeries held the maximum share in the autotransfusion devices market. The incidence of cardiac surgeries has increased in the past few years due to the increasing aging population and the rise in diabetic patients. Rise in smoking, high blood pressure, stress, etc. all lead to increase in the global cardiac surgeries autotransfusion devices market.
  • By End User: The report provides the bifurcation of the autotransfusion devices market into three segments based on end user: Hospital, Ambulatory Surgery Center and Speciality Clinics. The hospitals segment held the largest share of the global autotransfusion devices market. In hospitals, many patients walk in for diagnostics and a large number of patients are admitted for surgical procedures. As a result, hospitals currently hold a sizeable share in the market of autotransfusion devices, and this trend is anticipated to persist over the forecast period.
Geographic Coverage:
  • According to this report, the global autotransfusion devices market is divided into four regions: North America, Europe, Asia Pacific, and rest of the world. The countries covered in North America region include US, Canada, and Mexico, while Europe includes Germany, France, UK, Italy, Spain, and Rest of Europe. Moreover, China, Japan, India, South Korea, Australia, and the Rest of the Asia Pacific are included in the Asia Pacific region.
North America dominated the market with largest share of the global market. Factors such as the increasing prevalence of cancer in the US and Canada, rising number of patients suffering from cardiovascular, orthopedic diseases, an increase in the geriatric population, and surging cases of organs transplantation are the key factors driving the North America autotransfusion device market growth. Asia Pacific is anticipated to grow at the highest CAGR during the forecast period. Various government initiatives have helped in building necessary healthcare infrastructure, empowering healthcare providers and patients to opt for surgeries, hence boosting the demand for autotransfusion devices in the region.

Top Impacting Factors:

Growth Drivers

Increasing Healthcare Spending
  • High Bleeding Surgeries
  • Increasing Accident Cases
  • Less Availability of Rare Blood Group
Challenges
  • High Cost Involved
  • Removal of Beneficial Components from Blood
Trends
  • Increasing Market Consolidation
  • Technological Developments
  • Driver: Increasing Accident Cases
The victims of automobile accidents, their families, and entire nations suffer severe economic losses. These expenses are brought on by the cost of medical care, the loss of wages for those who pass away or become disabled as a result of their injuries, and the cost of caring for loved ones who must take time off from their jobs or studies to tend to the injured. Usually accident cases need urgent medical attention because of heavy blood loss and sometimes the blood of some particular type is not available in the blood bank of hospital. So the patient can get quick blood via autotransfusion device as the there is no need to wait for blood donor. So, the autotransfusion devices is anticipated to be in demand as the number of accidents rises.
  • Challenge: Removal of Beneficial Components from Blood
Blood is a vital thing for human survival, any kind of blood transfusion is a risky procedure as maintaining blood composition after transfusing in patient’s blood circulation is quite challenging. Another big concern is that these machines cannot extract pollutants from blood without removing and discarding blood constituents other than red blood cells.. This method may not be able to separate the undesirable stuff from the blood in some situations, and if operating mistakes or misuse occur, the machine may cause significant issues in the patient's body. Platelets and proteins such as clotting factors and albumin are among the helpful blood constituents that are eliminated. When blood loss is substantial, the removal of these components from blood might cause organ failure. As a result, the growth of autotransfusion devices may be slowed.
  • Trend: Increasing Market Consolidation
The consolidation phase is a stage in the industry life cycle where competitors in the industry start to merge. Companies would seek to consolidate to gain a larger portion of the overall market share and to take advantage of synergies. An increase in market size also provides an opportunity to expand the company's business line, which can lead to increased sales and profits as well. Therefore, the growing consolidation in the industry is expected to provide lucrative benefits and opportunities to the market leader in the coming years. Furthermore, several corporations used strategic actions such as acquisitions, partnerships, and others to gain market share. Medtronic, for example, bought AV Medical Technologies in October 2019. Getinge acquired Applikon Biotechnology in December 2019, which is the supplier of innovative bioreactor systems from the laboratory to the industrial scale. As a result, such improvements are anticipated to usher in new trends in the autotransfusion devices market in the future.

The COVID-19 Analysis:

The COVID-19 was reported as an infectious disease with a high mortality rate, and which restricts blood donation activities and make it worse for rare blood group patients. Surgeries like renal surgery, cardiovascular surgery, cancer treatment surgery were cancelled or delayed in fear of COVID-19 infection. As a result, COVID-19 had a short-term detrimental impact on the autotransfusion devices market. After the vaccination schedule was established and the rate of transmission was reduced, healthcare systems were restored to normal. Health care sector are increasingly integrating artificial intelligence to solve the post COVID-19 challenges. Growing aesthetics awareness, increased surgical adoption, and increased affordability of advanced treatments are expected to drive the growth of the autotransfusion devices market in the post-COVID period.

Analysis of Key Players:

The global autotransfusion device market is fragmented, with many players holding trivial market share. The key players of the globa autotransfusion device market are:
  • Becton, Dickinson & Company
  • Fresenius SE & Co.KGaA
  • Medtronic PLC
  • Zimmer Biomet Holdings Inc.
  • Stryker Corporation
  • LivaNova PLC
  • Braile Biomedica
  • ProCell Surgical Inc.
  • Haemonetic Corporation
  • SARSTEDT AG and Co.KG
  • Teleflex Incorporated
  • Getinge (Atrium Medical Corporation)
Some of the strategies among key players in the autotransfusion devices market are partnerships, mergers, acquisitions, and collaborations. For Instance, Zimmer Biomet acquired A&E Medical Corporation for US$150 million in cash at closing and US$100 million in cash payable in 2021. As per the terms of the acquisition, Zimmer Biomet acquired A&E Medical and its complete portfolio of sternal closure devices – including sternal sutures, cable systems, and rigid fixation. In October 2019, Medtronics Acquired AV Medical Technologies that operates as a medical device company. Similarly, Getinge acquired Applikon Biotechnology, which deals in developing and supplying advanced bioreactor systems from laboratory scale to production scale in December 2019.


1. Executive Summary
2. Introduction
2.1 Autotransfusion Devices: An Overview
Table 1: Features of Autotransfusion Devices
2.2 Autotransfusion Devices Segmentation: An Overview
2.2.1 Autotransfusion Devices Segmentation
Table 2: Auto Transfusion Segmentation
3. Global Market Analysis
3.1 Global Autotransfusion Devices Market: An Analysis
3.1.1 Global Autotransfusion Devices Market: An Overview
3.1.2 Global Autotransfusion Devices Market by Value
Table 3: Global Autotransfusion Devices Market by Value; 2017-2021 (US$ Billion)
Table 4: Global Autotransfusion Devices Market by Value; 2022-2027 (US$ Billion)
3.1.3 Global Autotransfusion Devices Market by Type (Product and Accessories)
Table 5: Global Autotransfusion Devices Market by Type; 2021 (Percentage, %)
3.1.4 Global Autotransfusion Devices Market by Application (Cardiac Surgeries, Orthopedic Surgeries, Trauma Procedures, and Others)
Table 6: Global Autotransfusion Devices Market by Application; 2021 (Percentage, %)
3.1.5 Global Autotransfusion Devices Market by End User (Hospital, Ambulatory Surgery Center, Specialty Clinics)
Table 7: Global Autotransfusion Devices Market by End User; 2021 (Percentage, %)
3.1.6 Global Autotransfusion Devices Market by Region (North America, Europe, Asia Pacific, and Rest of World)
Table 8: Global Autotransfusion Devices Market by Region; 2021 (Percentage, %)
3.2 Global Autotransfusion Devices Market: Type Analysis
3.2.1 Global Autotransfusion Devices Market by Type: An Overview
3.2.2 Global Autotransfusion Product Market by Value
Table 9: Global Autotransfusion Product Market by Value; 2017-2021 (US$ Million)
Table 10: Global Autotransfusion Product Market by Value; 2022-2027 (US$ Million)
3.2.3 Global Autotransfusion Product Market by Segments (Intraoperative, Postoperative and Dual Mode)
Table 11: Global Autotransfusion Product Market by Segments; 2021 (Percentage, %)
3.2.4 Global Autotransfusion Product Market Segments by Value
Table 12: Global Autotransfusion Product Market Segments by Value; 2021-2027 (US$ Million)
3.2.5 Global Autotransfusion Accessories Market by Value
Table 13: Global Autotransfusion Accessories Market by Value; 2017-2021 (US$ Million)
Table 14: Global Autotransfusion Accessories Market by Value; 2022-2027 (US$ Million)
3.3 Global Autotransfusion Devices Market: Application Analysis
3.3.1 Global Autotransfusion Devices Market by Application: An Overview
3.3.2 Global Cardiac Surgeries Autotransfusion Devices Market by Value
Table 15: Global Cardiac surgeries Autotransfusion Devices Market by Value; 2017-2021 (US$ Million)
Table 16: Global Cardiac surgeries Autotransfusion Devices Market by Value; 2022-2027 (US$ Million
3.3.3 Global Orthopedic Surgeries Autotransfusion Devices Market by Value
Table 17: Global Orthopedic Surgeries Autotransfusion Devices Market by Value; 2017-2021 (US$ Million)
Table 18: Global Orthopedic Surgeries Autotransfusion Devices Market by Value; 2022-2027 (US$ Million)
3.3.4 Global Trauma Procedures Autotransfusion Devices Market by Value
Table 19: Global Trauma Procedures Autotransfusion Devices Market by Value; 2017-2021 (US$ Million)
Table 20: Global Trauma Procedures Autotransfusion Devices Market by Value; 2022-2027 (US$ Million)
3.3.5 Global Others Autotransfusion Devices Market by Value
Table 21: Global Others Autotransfusion Devices Market by Value; 2017-2021 (US$ Million)
Table 22: Global Others Autotransfusion Devices Market by Value; 2022-2027 (US$ Million)
3.4 Global Autotransfusion Devices Market: End User Analysis
3.4.1 Global Autotransfusion Devices Market by End User: An Overview
3.4.2 Global Hospital Autotransfusion Devices Market by Value
Table 23: Global Hospital Autotransfusion Devices Market by Value; 2017-2021 (US$ Million)
Table 24: Global Hospital Autotransfusion Devices Market by Value; 2022-2027 (US$ Million)
3.4.3 Global Ambulatory Surgery Centers Autotransfusion Devices Market by Value
Table 25: Global Ambulatory Surgeries Autotransfusion Devices Market by Value; 2017-2021 (US$ Million
Table 26: Global Ambulatory Surgeries Autotransfusion devices Market by Value; 2022-2027 (US$ Million)
3.4.4 Global Specialty Clinics Autotransfusion Devices Market by Value
Table 27: Global Specialty Clinics Autotransfusion Devices Market by Value; 2017-2021 (US$ Million)
Table 28: Global Specialty Clinics Autotransfusion Devices Market by Value; 2022-2027 (US$ Million)
4. Regional Market Analysis
4.1 North America Autotransfusion Devices Market: An Analysis
4.1.1 North America Autotransfusion Devices Market: An Overview
4.1.2 North America Autotransfusion Devices Market by Value
Table 29: North America Autotransfusion Devices Market by Value; 2017-2021 (US$ Million)
Table 30: North America Autotransfusion Devices Market by Value; 2022-2027 (US$ Million)
4.1.3 North America Autotransfusion Devices Market by Region (The US, Canada, and Mexico)
Table 31 North America Autotransfusion Devices Market by Region; 2021 (Percentage, %)
4.1.4 The US Autotransfusion Devices Market by Value
Table 32: The US Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
4.1.5 The US Autotransfusion Devices Market by Type (Accessories, Intraoperative, Postoperative and Dual Mode)
Table 33: The US Autotransfusion Devices Market by Type; 2021 (Percentage, %)
4.1.6 The US Autotransfusion Devices Market Type by Value
Table 34: The US Autotransfusion Devices Market Type by Value; 2021-2027 (US$ Million)
4.1.7 The US Autotransfusion Devices Market by Application (Cardiac Surgeries, Orthopedic Surgeries, Trauma Procedures, and Others)
Table 35: The US Autotransfusion Devices Market by Application; 2021 (Percentage, %)
4.1.8 The US Autotransfusion Devices Market Application by Value
Table 36: The US Autotransfusion Devices Market Application by Value; 2021-2027 (US$ Million)
4.1.9 Canada Autotransfusion Devices Market by Value
Table 37: Canada Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
4.1.10 Mexico Autotransfusion Devices Market by Value
Table 38: Mexico Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
4.2 Europe Autotransfusion Devices Market: An Analysis
4.2.1 Europe Autotransfusion Devices Market: An Overview
4.2.2 Europe Autotransfusion Devices Market by Value
Table 39: Europe Autotransfusion Devices Market by Value; 2017-2021 (US$ Million)
Table 40: Europe Autotransfusion Devices Market by Value; 2022-2027 (US$ Million)
4.2.3 Europe Autotransfusion Devices Market by Region (Germany, France, UK, Italy, Spain, and Rest of the Europe)
Table 41: Europe Autotransfusion Devices Market by Region; 2021 (Percentage, %)
4.2.4 Germany Autotransfusion Devices Market by Value
Table 42: Germany Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
4.2.5 France Autotransfusion Devices Market by Value
Table 43: France Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
4.2.6 UK Autotransfusion Devices Market by Value
Table 44: UK Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
4.2.7 Italy Autotransfusion Devices Market by Value
Table 45: Italy Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
4.2.8 Spain Autotransfusion Devices Market by Value
Table 46: Spain Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
4.2.9 Rest of the Europe Autotransfusion Devices Market by Value
Table 47: Rest of the Europe Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
4.3 Asia Pacific Autotransfusion Devices Market: An Analysis
4.3.1 Asia Pacific Autotransfusion Devices Market: An Overview
4.3.2 Asia Pacific Autotransfusion Devices Market by Value
Table 48: Asia Pacific Autotransfusion Devices Market by Value; 2017-2021 (US$ Million)
Table 49: Asia Pacific Autotransfusion Devices Market by Value; 2022-2027 (US$ Million)
4.3.3 Asia Pacific Autotransfusion Devices Market by Region (Japan, China, India, South Korea, Australia and Rest of Asia Pacific)
Table 50: Asia Pacific Autotransfusion Devices Market by Region; 2021 (Percentage, %)
4.3.4 Japan Autotransfusion Devices Market by Value
Table 51: Japan Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
4.3.5 China Autotransfusion Devices Market by Value
Table 52: China Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
4.3.6 India Autotransfusion Devices Market by Value
Table 53: India Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
4.3.7 South Korea Autotransfusion devices Market by Value
Table 54: South Korea Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
4.3.8 Australia Autotransfusion Devices Market by Value
Table 55: Australia Autotransfusion Devices Market by Value; 2021-2027 (US$ Million)
4.3.9 Rest of Asia Pacific Autotransfusion Devices Market by Value
Table 56: Rest of Asia Pacific Autotransfusion Devices Market by Value; 2021-2027 (US$
4.4 Rest of World Autotransfusion Devices Market: An Analysis
4.4.1 Rest of World Autotransfusion Devices Market: An Overview
4.4.2 Rest of World Autotransfusion Devices Market by Value
Table 57: Rest of World Autotransfusion Devices Market by Value; 2017-2021 (US$ Million)
Table 58: Rest of World Autotransfusion Devices Market by Value; 2022-2027 (US$ Million)
5. Impact of COVID-19
5.1 Impact of COVID-19 On Autotransfusion Devices Market
5.2 Cancellation of Surgeries during COVID-19
Table 59: Global Total Cancelled Operations over a 12-week Period of Peak Disruption, by Specialty and Region; 2020 (Thousand)
5.3 Post COVID-19 Impact on Autotransfusion Device Market
6. Market Dynamics
6.1 Growth Driver
6.1.1 Increasing Healthcare Spending
Table 60: Global Healthcare Spending Per Head by Region; 2018-2022 (US$)
6.1.2 High Bleeding Surgeries
6.1.3 Increasing Accident Cases
6.1.4 Less Availability of Rare Blood Group
6.1.5 Increasing Prevalence of Chronic Diseases
6.1.6 Rising Number of Transplants
Table 61: Global Number of Transplants by Region; 2020-2021
6.1.7 Rapid Urbanization
Table 62: Global Urban Population; 2015, 2020 & 2050 (Million)
6.2 Challenges
6.2.1 High Cost Involved
6.2.2 Removal of Beneficial Components from Blood
6.3 Market Trends
6.3.1 Increasing Market Consolidation
6.3.2 Technological Developments
7. Competitive Landscape
7.1 Global Autotransfusion Device Market Players by Product Comparison
Table 63: Global Autotransfusion Device Market Players by Product Comparison
8. Company Profiles
8.1 Medtronic PLC
8.1.1 Business Overview
8.1.2 Operating Segments
Table 64: Medtronic PLC Revenue by Segment; 2021 (Percentage, %)
8.1.3 Business Strategy
8.2 Fresenius SE & Co. KGaA
8.2.1 Business Overview
8.2.2 Operating Segments
Table 65: Fresenius SE & Co. KGaA Sales by Segment; 2021 (Percentage, %)
8.2.3 Business Strategy
8.3 Braile Biomedica
8.3.1 Business Overview
8.3.2 Business Strategy
8.4 Haemonetics Corporation
8.4.1 Business Overview
8.4.2 Operating Segments
Table 66: Haemonetics Revenues by Segment; 2022 ( Percentage, %)
8.4.3 Business Strategy
8.5 SARSTEDT AG & Co. KG
8.5.1 Business Overview
8.5.2 Business Strategy
8.6 Teleflex Incorporated
8.6.1 Business Overview
8.6.2 Operating Segments
Table 67: Teleflex Incorporated Net Revenues by Segments; 2021 (Percentage, %)
8.6.3 Business Strategy
8.7 Becton, Dickinson & Company
8.7.1 Business Overview
8.7.2 Operating Segments
Table 68: Becton, Dickinson & Company Revenues by Segment; 2021 (Percentage, %)
8.7.3 Business Strategy
8.8 LivaNova, PLC
8.8.1 Business Overview
8.8.2 Operating Segments
Table 69: LivaNova PLC Net Sales by Segment: 2021 (Percentage; %)
8.8.3 Business Strategy
8.9 ProCell Surgical Inc.
8.9.1 Business Overview
8.9.2 Business Strategy
8.10 Getinge (Atrium Medical Corporation)
8.10.1 Business Overview
8.10.2 Operating Segments
Table 70: Getinge Net Sales by Segment; 2021 ( Percentage; %)
8.10.3 Business Strategy
8.11 Stryker Corporation
8.11.1 Business Overview
8.11.2 Operating Segments
Table 71: Stryker Corporation Net Sales by Segment; 2021 (Percentage, %)
8.11.3 Business Strategy
8.12 Zimmer Biomet Holdings, Inc.
8.12.1 Business Overview
8.12.2 Operating Segments
Table 72: Zimmer Biomet Holdings, Inc. Sales by Segment; 2021 (Percentage, %)
8.12.3 Business Strategy

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings